Thomas (Tom) Wellner

Tom Wellner is a highly experienced corporate executive who recently retired as President and Chief Executive Officer of Revera Inc., a leading global owner, operator and developer in the senior living/healthcare sector. With over three decades of substantial global experience in biotechnology, pharmaceuticals, and healthcare services, Mr. Wellner has led several organizations, including President/CEO of Lilly Germany GmbH, President/CEO LifeLabs/CML Healthcare, Ltd., and President/CEO Therapure Biopharma.

He has been a guest lecturer on international business and healthcare at Harvard, Rotman and INSEAD Schools of Business, and has been engaged in significant advisory work within public equity and venture capital communities. He currently serves on the Ontario Teachers’ Pension Plan (OTPP) Board where is a member of the Investment, Audit and Risk Committees. He is also on the board of Andlauer Health Group, TSX:AHG where he chairs the audit committee and has previously served on the boards of FreshBooks, Novadaq Technologies, Cipher Pharmaceuticals, various Revera entities including Sunrise Senior Living and has been an advisor to Lumira Capital.

Mr. Wellner holds an Honours Bachelor of Science degree in Life Sciences from Queen’s University and has received the ICD.D designation from the Institute of Corporate Directors.